• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

cerusendovascular

FDA grants IDE approval for Cerus Endovascular’s Contour Neurovascular System clinical study

April 21, 2021 By Sean Whooley

Cerus Endovascular announced today that it received FDA investigational device exemption for a trial for its Contour Neurovascular System. Fremont, Calif.–based Cerus’ Contour Neurovascular System is designed to treat intracranial aneurysms. Its creators made it of fine mesh braid to target the neck of the aneurysm away from the vulnerable dome. It’s possible to self-anchor […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Neurological, Pre-Market Approval (PMA), Regulatory/Compliance, Vascular Tagged With: Cerus Endovascular, cerusendovascular, FDA

Cerus Endovascular neurovascular system wins FDA breakthrough device designation

February 11, 2021 By Danielle Kirsh

Cerus Endovascular today said it has received FDA breakthrough device designation for its Contour Neurovascular System. The Contour Neurovascular System is designed to treat intracranial aneurysms. It is made of fine mesh braid to target the neck of the aneurysm away from the vulnerable dome. It can be self-anchored for stability, is re-sheathable for precise […]

Filed Under: Food & Drug Administration (FDA), Neurological, Vascular Tagged With: cerusendovascular

Cerus announces first robot-assisted intracranial implant

December 18, 2020 By Sean Whooley

Cerus Endovascular announced that it completed the first robot-assisted intracranial implant of its Contour intrasaccular device. Fremont, Calif.-based Cerus said in a news release that the procedure was the first-ever robotically assisted intracranial implant of the Contour device. It was completed at the King Edward Memorial Hospital in Mumbai by Dr. Nitin Dange. Dr. Dange […]

Filed Under: Featured, Neurological, Surgical, Surgical Robotics Tagged With: cerusendovascular, Robotic Surgery

Cerus Endovascular and Balt partnered to deliver Contour Neurovascular System in Germany

August 5, 2020 By Danielle Kirsh

Cerus Endovascular and Balt this week announced a strategic distribution agreement to provide AB Medica with the exclusive rights to market and sell the Countour Neurovascular System and the Neqstent Coil Assisted Flow Diverter devices. The distribution agreement is currently limited to Germany. The financial details of the deal were not disclosed. “Our partnership with […]

Filed Under: Neurological Tagged With: Balt, cerusendovascular

Cerus Endovascular wins CE mark approval for Contour Neurovascular System

April 29, 2020 By Danielle Kirsh

Cerus Endovascular today said it received CE mark approval for its 021 Contour Neurovascular System. The system is compatible with smaller commercially available 021 microcatheters to treat saccular intracranial aneurysms. It features a fine mesh braid that is deployed across the next of the aneurysm sac for flow diversion and flow disruption in a single […]

Filed Under: Neuromodulation/Neurostimulation Tagged With: cerusendovascular

Cerus Endovascular receives CE Mark for aneurysm treatment

February 18, 2020 By Sean Whooley

Cerus Endovascular announced today that it won CE Mark approval for its Contour neurovascular system for treating intracranial aneurysms. The Contour system is a mesh braid designed to be deployed across the neck of an aneurysm sac, providing flow diversion and flow disruption in combination through a single device implant. Contour is also designed to […]

Filed Under: Business/Financial News, Featured, Neurological, News Well, Regulatory/Compliance Tagged With: CE Mark, cerusendovascular

Cerus Endovascular tops $5m funding goal, raises target to $20m

August 28, 2019 By Nancy Crotti

Cerus Endovascular raised its fundraising goal to $20 million this week after it pushed past its previous $5 million target by about $900,000, according to a regulatory filing. The Oxford, U.K.-based company is developing the Contour neurovascular system, which is designed to reduce the risk of rupture when treating patients with intracranial aneurysms. The Contour […]

Filed Under: Business/Financial News, Funding Roundup, Neurological, News Well Tagged With: cerusendovascular

Cerus Endovascular starts European trial of intracranial aneurysm device

November 15, 2018 By Nancy Crotti

Cerus Endovascular said it has enrolled the first patients in a study designed to assess the safety of the company’s Contour neurovascular system, which is designed to reduce the risk of rupture when treating patients with intracranial aneurysms. Intracranial aneurysms occur at the rate of nine per 100,000 with a wide range; in some countries, the rate is […]

Filed Under: Clinical Trials, Neurological, Research & Development, Vascular Tagged With: cerusendovascular

7 medtech stories we missed this week: April 27, 2018

April 27, 2018 By Danielle Kirsh

From DuPuy Synthes’s spinal implant launch to Lumendi’s FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. DePuy Synthes launches spinal implants DePuy Synthes announced in an April 26 press release that it has launched its Proti 360º integrated titanium family of interbody devices that are designed […]

Filed Under: 510(k), Diagnostics, Food & Drug Administration (FDA), Hospital Care, Implants, Regulatory/Compliance, Surgical, Weight loss Tagged With: Abbott, Apollo Endosurgery, cerusendovascular, depuysynthes, Lumendi, MedTech, Pavmed, ReShape Lifesciences, sanquin

Cerus Endo wins CE Mark for Contour neurovascular aneurysm system

July 7, 2017 By Fink Densford

Updated to correct that the company is Cerus Endovascular, with no relation to Cerus Corp. Cerus Endovascular said today it won CE Mark approval in the European Union for its Contour neurovascular system designed for treating intra-cranial aneurysms. The Fremont, Calif.-based company said the Contour system is designed with a fine mesh braid deployed at the […]

Filed Under: Regulatory/Compliance, Vascular Tagged With: cerusendovascular

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy